Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular Carcinoma

Global cancer statistics

2011 • 55,498 citations

The Hallmarks of Cancer

2000 • 27,569 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2004 • 11,185 citations

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2001 • 11,070 citations

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2000 • 9,712 citations

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

2004 • 9,201 citations

Cancer genes and the pathways they control

2004 • 4,172 citations

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

1997 • 3,847 citations

Wnt signalling in stem cells and cancer

2005 • 3,593 citations

Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC ^−/− Colon Carcinoma

1997 • 3,234 citations

WNT and β-catenin signalling: diseases and therapies

2004 • 1,703 citations

Biomarkers in Cancer Staging, Prognosis and Treatment Selection

2005 • 1,613 citations

Caught up in a Wnt storm: Wnt signaling in cancer

2003 • 1,473 citations

Molecular pathogenesis of human hepatocellular carcinoma

2002 • 1,424 citations

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

2006 • 1,129 citations

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

2006 • 911 citations

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

2004 • 874 citations

Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

2003 • 837 citations

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment

2006 • 811 citations

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

1979 • 638 citations

Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex

2004 • 629 citations

Colorectal cancer and genetic alterations in the Wnt pathway

2006 • 575 citations

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

2001 • 567 citations

The biology of the 17–1A antigen (Ep-CAM)

1999 • 541 citations

EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy

2004 • 533 citations

Apoptosis and APC in colorectal tumorigenesis.

1996 • 491 citations

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

2006 • 358 citations

The Phenotypes of Pluripotent Human Hepatic Progenitors

2006 • 336 citations

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

2004 • 308 citations

Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages

2006 • 301 citations

FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development

2004 • 292 citations

Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

2003 • 285 citations

Molecular pathogenesis of human hepatocellular carcinoma

2002 • 259 citations

Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma

2004 • 243 citations

Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver

1999 • 237 citations

β-catenin antisense studies in embryonic liver cultures: Role in proliferation, apoptosis, and lineage specification

2003 • 216 citations

From Proteomic Analysis to Clinical Significance

2003 • 187 citations

β-Catenin is temporally regulated during normal liver development☆

2004 • 184 citations

Identification of BMP and Activin Membrane-bound Inhibitor (BAMBI), an Inhibitor of Transforming Growth Factor-β Signaling, as a Target of the β-Catenin Pathway in Colorectal Tumor Cells

2004 • 152 citations

Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease

2005 • 151 citations

Wnt/frizzled signaling in hepatocellular carcinoma

2006 • 150 citations

Involvement of Crm1 in Hepatitis B Virus X Protein-Induced Aberrant Centriole Replication and Abnormal Mitotic Spindles

2003 • 140 citations

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis

2004 • 138 citations

Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma

2006 • 115 citations

Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. A review

2006 • 107 citations

Distinctive gene expression profiles associated with Hepatitis B virus x protein

2001 • 97 citations

Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinoma

2005 • 26 citations